(Q37189727)

18 August 2017

1 reference

title

Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

Joel R Saper

1

1 reference

PubMed ID

18549361

18 August 2017

Alvin E Lake

series ordinal

2

1 reference

18 August 2017

1 June 2008

1 reference

18 August 2017

1 reference

18 August 2017

48

1 reference

18 August 2017

6

1 reference

18 August 2017

838-849

1 reference

Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review

18 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Measuring pain as the 5th vital sign does not improve quality of pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Kindness kills: the negative impact of pain as the fifth vital sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Pain disability index: construct and discriminant validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

The Pain Disability Index: psychometric properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Opioids in chronic non-cancer pain, indications and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Critical issues on opioids in chronic non-cancer pain: an epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Age-dependent opioid escalation in chronic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Age-dependent morphine tolerance development in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Side effects of opioids during short-term administration: effect of age, gender, and race

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

A survey of chronic noncancer pain patients prescribed opioid analgesics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Medication-induced (analgesic rebound) headache: historical aspects and initial descriptions of the North American experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Evidence-based understanding of medication-overuse headache: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Opiate use to control bowel motility may induce chronic daily headache in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Medication-overuse headache: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Modifiable risk factors for migraine progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

The outcome of treating patients with suspected rebound headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Medication-overuse headache: description, treatment, and relapse prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Opioid-induced hyperalgesia: a qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Opioid-induced abnormal pain sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

A genetic analysis of opioid-induced hyperalgesia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

The spinal basis of opioid tolerance and physical dependence: Involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Role of NK-1 neurotransmission in opioid-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Antinociceptive and nociceptive actions of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Glia: novel counter-regulators of opioid analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Glial activation: a driving force for pathological pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Opioids as modulators of cell death and survival--unraveling mechanisms and revealing new indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Characterization of methadone overdose: clinical considerations and the scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

A community-based evaluation of sudden death associated with therapeutic levels of methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Neurodevelopmental outcome after prenatal exposure to opiates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Foster-placed and adopted children exposed in utero to opiates and other substances: prediction and outcome at four and a half years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Investigating the effects of TTS-fentanyl for cancer pain on the psychological status of patients naïve to strong opioids: an open label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

In vivo quantitative proton MRSI study of brain development from childhood to adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Mapping brain maturation and cognitive development during adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Clinical aspects and treatment of pain in children and adolescents with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

The relationship of psychological and cognitive factors and opioids in the development of the postconcussion syndrome in general trauma patients with mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

Development of the Social Brain during Adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01153.X

10.1111/J.1526-4610.2008.01153.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18549361